Twitter Logo Youtube Circle Icon LinkedIn Icon

France > Intellectual property > Patents > Law firm and leading lawyer rankings


Index of tables

  1. Intellectual property: patents
  2. Other recommended firms
  3. Leading individuals

Leading individuals

  1. 1

The ‘excellentAllen & Overy LLP is recommended for high-value pharmaceutical patent cases, including cases aiming to change the law in France. It recently obtained a ruling in favour of the patentability of dosage regime from the Paris Court of Appeals for client Merck Sharp & Dohme. Other strong areas of expertise are telecoms and hi-tech. The practice is notably handling several cases regarding essential standard patent infringement issues. It represented Samsung in IP litigation against Apple Inc. Daiichi Sankyo and Google are also clients. Practice head Laëtitia Bénard has ‘an excellent knowledge of the industry, the courts and the law’, and is ‘an advocate for bringing France to the forefront of modern pharmaceutical patent practice’. The ‘pragmatic and tenacious’ David Por and recently promoted partner Alexandre Rudoni are also recommended.

Bird & Bird has ‘a good knowledge of the pharmaceuticals sector, providing good strategic advice on patent litigation’. The firm is handling high-profile cases in the area for clients such as Actavis. The practice also manages high-end telecoms litigation. Practice head Yves Bizollon is a ‘high-quality’ adviser; other names to note are Géraldine Arbant, who recently joined from Fidal, as well as Anne-Charlotte Le Bihan and Marc Schuler.

Gide Loyrette Nouel A.A.R.P.I. has strong patent litigation expertise, especially in the pharmaceuticals industry, and regularly acts for new entrants. The 19-lawyer IP team has also been involved in obtaining key results in a high-profile telecoms dispute on behalf of Nokia Siemens Networks. The firm also successfully defended La Maison du Café at first instance to cancel some of Nestlé’s patents on Nespresso coffee machines capsules. The practice is led by the highly regarded Grégoire Triet, Arnaud Michel, Emmanuel Larere and Raphaëlle Dequiré-Portier.

Hoyng Rokh Monegier is ‘a go-to firm’ for patent litigation and ‘can handle national and international disputes’. The 11-lawyer team ‘has deep technical knowledge and good commercial understanding’ in many areas, but most notably in pharmaceuticals, where it is defending several blockbuster drug patents and advises on the development of biosimilars in strategic pan-European disputes. The firm is also representing Merck Sharp & Dohme Animal Health and Intervet International in patent infringement litigation against Bayer. The highly regarded Denis Monégier du Sorbier heads the practice jointly with Sophie Micallef, Marie Georges-Picot and Benoît Strowel, who is ‘hugely experienced and has a great understanding of clients’ needs’.

Cabinet Schertenleib is ‘especially recommended for technical patent litigation, particularly in the life sciences field’. The boutique has ‘excellent knowledge of the French pharmaceuticals industry’, where it is handling an impressive strategic caseload. The firm is assisting generics companies such as Mylan in blockbuster patent litigation, and is also involved in innovative cases pertaining to patents on antibodies. It is representing Eli Lilly in a patent revocation litigation regarding Alzheimer’s disease therapeutic monoclonal antibodies held by Janssen Sciences Ireland. The practice is led by French and English-qualified lawyer Denis Schertenleib, who is ‘technically adept on both patent law and technology’. Of counsel Ombeline Degrèze-Péchade has ‘excellent regulatory knowledge of life sciences’.

Véron & Associés’ team is made up of ‘patent experts who have scientific knowledge’ and ‘are always up to date on the latest trends in France and in Europe’. The 12-lawyer team is recommended for high-stakes litigation and has expertise in various areas; notably in strategic biosimilar cases in the healthcare sector. The firm recently successfully defended Airbus Helicopters in a landing gear patent dispute with Bell. Key figures in the practice include Pierre Véron, Isabelle Romet, Thomas Bouvet, as well as Sabine Agé and Amandine Métier, whose ‘listening abilities and pertinent advice’ are particularly appreciated.

August Debouzy’s ‘very proactive’ nine-lawyer team is ‘there 24/7 and always finds a solution’. The practice is particularly strong in the healthcare area, where it is handling pan-European litigation for clients such as Teva. The firm also acts for leading telecoms clients, including Orange. The team successfully represented Ericsson in a dispute with High Point. Other active sectors include energy, defence and research and development. The team is headed by Grégoire Desrousseaux and ‘brilliant European patent lawyerFrançois Pochart.

Dechertquickly jumps into complex cases, providing sophisticated, highly responsive advice and representation’. The ‘impressive’ five-lawyer team has ‘strong cross-border and international experience’ and is adept at serving US clients. The firm is handling complex and high-end cases pertaining to telecoms, electronics, construction, chemicals and life sciences. Johnson & Johnson and LG Electronics are clients. Practice head Marianne Schaffner is ‘a valued adviser able to manage complex and sensitive issues rapidly and in the best way possible’. ‘Rising star’ Romain Viret ‘really understands the technology behind the patents’.

Hogan Lovells (Paris) LLP has strong expertise in the healthcare sector and regularly represents leading pharmaceuticals groups in domestic and multi-jurisdictional litigation with new entrants. It is representing Hollister in a patent infringement case initiated by Coloplast. The firm also handles patent disputes in other sectors and advises on IP in the context of corporate transactions. Clients include Eli Lilly and Lear Corporation. Stanislas Roux-Vaillard is the key contact.

Lavoix Avocats is involved in a number of landmark FRAND cases. The practice represented Myriad in US and London proceedings with Oracle America, and successfully acted for LGE in a case against Core Wireless in Paris. Cyrille Amar heads the six-lawyer IP practice, which includes strong names Grégoire Goussu and Antonin Staub.

Loyer & Abelloprovides excellent and very pragmatic assistance’. The five-lawyer team is ‘to the point, efficient and result-driven’ and ‘has very large experience in court’. The practice represents many major groups, including handling key matters in the healthcare sector, where it is defending Teva following the launch of a generic drug a few months before MSD’s SPCs expired. The firm is also acting for Gaztransport and Technigaz in proceedings with Chantiers de l’Atlantique. Practice head Michel Abello is ‘highly competent and a very good negotiator’.

Reed Smith’s ‘excellent’ five-lawyer team is renowned for its patent expertise in the healthcare sector, where it takes on strategic disputes against generics manufacturers. The firm is notably representing Alkermes Pharmaceutical and Abbott Laboratories in blockbuster patent infringement litigation. It is also handling cases in the telecoms and mechanical engineering sectors. ‘A very talented and experienced litigator’, practice head Marina Cousté has ‘extraordinary ability’. François Jonquères is another name to note.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

GC Powerlist -

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in France

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • The new French regulation applying to national insurance contributions for managers and shareholders

    French insurance contributions on executive and shareholder remuneration (pay + dividends) have been substantially increased by the National Insurance Funding for 2013 Act, No. 2012-1404, of 17th December 2012. Until 31st December 2012, all dividends were subject to national insurance contributions on unearned income but henceforth, under Article L136-3 of the National Insurance Code, amended by Act No. 2012-1404, certain dividends   are considered as pay received by executives and shareholders and are therefore subject to the national insurance contributions on pay. The Act also abolished the ceiling on health insurance contributions payable by the self-employed and all this means that businesses must rethink the way that they have been structured until now.

    The People's Republic of China has initiated an overhaul of its social security system, reformed the personal taxation regime and has extended the scope of these laws to foreigners residing in China.

    The Kingdom of Morocco is supporting the ambition of becoming the leading financial place for Africa. In this context, a wave of draft laws is to be passed and implemented within the following months, amongst which, the Law No. 53.08, setting up a new financial authority, and the Law No. 54.08, reforming public offering rules, are of paramount importance to Moroccan and foreign issuers, and financial institutions.

    The opportunities offered to foreign investors by the Chinese mergers and acquisitions market are increasing every year: in 2010, transactions involving foreign companies came to 60.1 billion euros, an increase of 21.2% compared with 2009. Seen from the West, where markets are declining, all sectors of the Chinese economy seem to be undergoing promising development and the statistics indicate that the Middle Empire will be a lasting springboard for growth.
  • Prime de Partage des Profits

    Le dispositif L’article 1er de la loi de financement rectificative de la Sécurité sociale pour 2011 oblige les sociétés commerciales de 50 salariés et plus, dont les dividendes par part sociale ou par action sont en augmentation par rapport à la moyenne des deux années précédentes, à verser une prime à l’ensemble de leurs salariés

    Types of investors The private equity (PE) funds that are active in Bulgaria are not raised or registered in the country. Some Bulgarian PE funds were raised recently, but there are no statistics as to the sources of their funding, their number, the funds that were accumulated, etc.

  • Landmark decision by French Competition Authority in conditioned LPG case

    cartel case closed after discovery that leniency application was largely based on forgeries and rejection of collective dominant position objection.
  • 2012 supplementary budget

    The second supplementary budget published in the Official Gazette September 19, 2011 provides for two key measures that affect the deferral of tax losses and taxation of capital gains realized on the sale of equity securities .
  • Actualité législative fiscale

    Au delà des mesures applicables à l’ensemble des contribuables (telles que la limitation du report des déficits ou la réforme du mode de calcul des plus values sur cessions de participations),le plan de réduction des déficits annoncé le 24 août dernier par le gouvernement comprend des mesures qui intéressent spécifiquement les acteurs du secteur financier.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to